Regulatory affairs

Iqvia launches patient portal that provides trial participants with study updates, outcomes

15-Aug-2019 By Melissa Fassbender

Iqvia today launches its new patient portal, designed to support clinical trial participants throughout the process with a “direct connection to the clinical research environment,” says company executive.

Traceability is key in the growing global cold chain market

14-Aug-2019 By Maggie Lynch

As the pharmaceutical industry grows globally, the market for cold chain technology, solutions, and innovations is working to keep pace.

On the industrialization of cell and gene therapy manufacturing: No scale without a seamless supply chain

14-Aug-2019 By Maggie Lynch

The cell and gene therapy industry cannot grow without a ‘standardized, systematized, industrialized foundation,’ according to experts from Lonza and Vineti, which have teamed up to advance a ‘vein-to-vein’ delivery network.

‘A tsunami of change coming to clinical development’: AbbVie talks digital disruption

07-Aug-2019 By Maggie Lynch

At a time when innovation is rapid, clinical development is evolving at the same pace, and new technologies are bringing disruptive opportunities to research, says AbbVie executive.

‘The future is challenging us to innovate our delivery methods’: PRA

06-Aug-2019 By Melissa Fassbender

Biopharmaceutical companies are increasingly relying on CROs in Japan, says an executive with PRA, which recently established a new subsidiary in the country.

People on the Move: Outsourcing-Pharma roundup July ‘19

02-Aug-2019 By Melissa Fassbender

CordenPharma has a new CEO, Arbour Group advances plans to expand in RTP, Ashfield brings on a former Iqvia VP, and Recursion adds to its c-suite after raising $121m this month.

Iqvia sees ‘a lot of runway ahead’ despite growth in Q2

30-Jul-2019 By Maggie Lynch

Iqvia is looking to the future and opportunities in AI, after reporting $2.74bn in revenue for Q2 FY19.

Veristat opens office in Taiwan to support ‘fast-growing' clinical development market

29-Jul-2019 By Maggie Lynch

Veristat launches clinical trial, biostatistics, and programming operations in Taipei, Taiwan in response to increasing client demand for regulatory submission support for both local and North American-based sponsors.

Global infectious disease drug development partnership aims to ‘stimulate pharma’

29-Jul-2019 By Maggie Lynch

Penta and Cromsource partner in an aim to improve pediatric drug development for infectious disease therapies worldwide.

Universal flexible partnering agreement to ease drug discovery partnerships: Insilico

25-Jul-2019 By Maggie Lynch

Insilico Medicine develops a semi-automated contracting system to ease the collaboration process between AI companies and industry partners in the discovery space.

The Living Heart: FDA renews contract with Dassault to evaluate 3D simulation, virtual patients

24-Jul-2019 By Melissa Fassbender

Dassault Systèmes’ Living Heart Project is moving forward with an in silico clinical trial underway and plans to evaluate the use of virtual patients – as the French software company hopes to reduce costs, timelines, and improve quality across the industry,...

Parexel opens consulting subsidiary in Hong Kong

23-Jul-2019 By Melissa Fassbender

Parexel’s consulting subsidiary Health Advances opens in Hong Kong to provide business strategy as well as scientific and clinical expertise to customers in the region.

Consortium creates a ‘behavioral biomarker’ through AI models

23-Jul-2019 By Maggie Lynch

The AI technology company BlackThorn joins a consortium to develop predictive models for neurobehavioral disorder clinical trial inclusion criteria.

‘Upper echelons of administration’ recognize need for growth in kidney disease treatments

19-Jul-2019 By Maggie Lynch

An Executive Order signed by President Trump aims to increase research, incentives, and treatment access for kidney disease patients and could 'fundamentally transform kidney therapeutics,' says president of the American Society of Nephrology....

Marken acquires three European firms, assessing additional deals: ‘Stay tuned,’ says CEO

18-Jul-2019 By Melissa Fassbender

Marken has purchased three European logistics firms and is assessing additional locations at which the CEO said it plans to either build or buy.